Active Funding Opportunity Announcements (FOAs) for All NICHD

NICHD issues and participates in various FOAs to support research activities and training.

Investigator-Initiated (Unsolicited) Projects

To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.

Active FOAs for NICHD

Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.

Announcement Number Submissions Date(s) Expiration Date Activity Code(s) Title
PA-18-373 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. January 8, 2021 K08 Mentored Clinical Scientist Research Career Development Award (Parent K08 - No Independent Clinical Trials)
PA-18-363 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The first standard due date for this FOA is February 12, 2018.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2021 K01 Mentored Research Scientist Development Award (Parent K01 - Clinical Trial Required)
PA-18-369 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The first standard due date for this FOA is February 12, 2018.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
January 8, 2021 K01 Mentored Research Scientist Development Award (Parent K01 -Independent Clinical Trial Not Allowed)
PAR-18-411 March 14, 2018; March 14, 2019; March 13, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
March 14, 2020 R01 Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)
PA-18-049 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The first standard application due date for this FOA is June 16, 2017.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
May 8, 2020 R21 Fertility Status as a Marker for Overall Health (R21 Clinical Trial Optional)
PA-18-047 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. January 8, 2020 R21 Trophoblast Differentiation and Function (R21 Clinical Trial Optional)
PA-18-048 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. January 8, 2020 R21 Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)
PA-18-093 Multiple dates, see announcement. May 8, 2019 R21 Oocyte Mitochondrial Function in Relation to Fertility, Aging, and Mitochondrial Diseases (R21 Clinical Trial Optional)
RFA-MH-18-510 March 15, 2018; December 7, 2018; August 7, 2019; April 7, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates April 8, 2020 F32 BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
PAR-18-206 Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2019 R01 Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
PA-18-141 Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2019 R01 Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional)
PA-18-159 Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2019 R21 Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional)
PA-18-089 Multiple dates, see announcement. May 8, 2019 R01 Multidisciplinary Research in Vulvodynia (R01 Clinical Trial Optional)
PAR-18-095 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2019 R03 Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R03 Clinical Trial Optional)
PA-18-096 Multiple dates, see announcement. May 8, 2019 R21 Multidisciplinary Research in Vulvodynia (R21 Clinical Trial Optional)
PAR-18-091 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2019 R01 Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01 Clinical Trial Optional)
PAR-18-094 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. May 8, 2019 R21 Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R21 Clinical Trial Optional)
PA-18-343 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard due date for this FOA is February 25, 2018
January 8, 2021 R15 Academic Research Enhancement Award (R15 Clinical Trial Required)
PA-18-043 Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. January 8, 2020 R21 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional)
PA-18-044 Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. January 8, 2020 R03 Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional)